AUG 16, 2017 02:42 PM PDT

Cancer drugs take aim at viruses

WRITTEN BY: Kerry Evans

Researchers at the National Institute of Allergy and Infectious Disease knew that some viruses - herpes simplex virus, for example - integrate their own genomes into their host’s genome, where viral gene expression is subject to host epigenetic regulation. They also knew that some cancer drugs work by targeting epigenetic modifications that make cancer cells proliferate. Putting two and two together, they reasoned that these epigenetic drugs might also work as antiviral drugs.

HSV is subject to epigenetic regulation.

Image: Thermo Fisher Scientific

Principal investigator Thomas Kristie and his team investigated the antiviral activity of EZH2/1 inhibitors. EZH 2 and 1 are histone methyltransferases that generate H3K27 methylation domains which repress gene expression. Some cancers are driven by gain-of-function mutations in EZH2.   

To determine if EZH2/1 inhibitors could suppress herpes simplex virus (HSV) gene expression and proliferation, the researchers treated human fibroblasts with 1 of 3 EZH2/1 inhibitors for 5 hours and infected the cells with HSV. Sure enough, the inhibitors suppressed HSV gene expression.

Next, they wanted to determine if the EZH2/1 inhibitors induced an antiviral state in the host cells that suppressed HSV. Indeed, they found an increase in the expression of IFN-alpha and IL-8 (antiviral cytokines) in cells treated with the EZH2/1 inhibitor GSK126. Further investigation showed that cells produced an antiviral response within just 2 hours of being treated with the inhibitor.

Because the EZH2/1 inhibitors induced a general antiviral state, the researchers wanted to know if these drugs could suppress the growth of other viruses. Indeed, the inhibitors suppressed the expression of immediate early genes in Ad5 (an adenovirus) and hCMV. All of the viruses tested up to this point were DNA viruses, so next they determined if the EZH2/1 inhibitors had an effect on RNA viruses.

To test this, they treated human fibroblast with GSK126 and then infected them with Zika virus (an RNA virus). GSK126 reduced the number and size of viral plaques in cell culture, indicating that GSK126 suppressed Zika virus infection.

Finally, they used a mouse model to test the effects of EZH2/1 inhibitors in vivo. The researchers infected the mice with HSV by either the ocular or oral route then treated the animals with an EZH2/1 inhibitor. For the ocular infection, the EZH2/1 inhibitors significantly reduced viral yields within just 3 days of treatment. Similar results were reported for the intranasal infection.

So, what’s the next step? According to Kristie, “for emerging viruses for which there aren't any immediate treatments, this may be something that could be used to boost an individual's innate immunity. This could also be a novel way of treating infections by enhancing the infected cell's own ability to fight the virus.”

Sources: mBio and Science Daily

 

About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
OCT 01, 2018
Microbiology
OCT 01, 2018
A Virus That can Help Ensure Water is Clean
It's estimated that 780 million people worldwide don't have access to clean drinking water....
OCT 02, 2018
Videos
OCT 02, 2018
Learning how Bacterial Chemicals Impact Human Health
We play host to a huge number of microbes, and all the chemicals that they produce....
OCT 23, 2018
Microbiology
OCT 23, 2018
DNA Pumps up Bacterial Cells
Cells are the basic building blocks of life, and have been well-studied since they were discovered in 1655....
NOV 23, 2018
Microbiology
NOV 23, 2018
Researchers Surprised to Find Giant Viruses in Forest Soil
Viruses were thought of as tiny infectious agents for the most part, until researchers began to discover more and more giant viruses....
DEC 07, 2018
Microbiology
DEC 07, 2018
Epigenetic Inheritance is Revealed in Archaea
Researchers may have found a great new way to study tags that are added to the genome, which change how genes are expressed....
DEC 12, 2018
Cell & Molecular Biology
DEC 12, 2018
Study Shows Why Diets Rich in Red Meat Increase Heart Disease Risk
For decades, we've known that red meat is a risk factor for heart disease. Now, researchers at the Cleveland Clinic know why....
Loading Comments...